Scholar Rock prices upsized $85M offering (NASDAQ:SRRK)
Phase 3 clinical-stage biopharmaceutical company Scholar Rock (NASDAQ:SRRK) priced an upsized underwritten public offering of 12.41M shares at a public ...
Phase 3 clinical-stage biopharmaceutical company Scholar Rock (NASDAQ:SRRK) priced an upsized underwritten public offering of 12.41M shares at a public ...
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.
© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.